Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Nebulization for Pain After Laparoscopic Cholecystectomy
NCT01143025Phase 3Completed
- Sponsor
- Fondazione IRCCS San Gerardo dei Tintori
- Start
- Mar 2010
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (3 arms), sponsored by Fondazione IRCCS San Gerardo dei Tintori. Primary endpoint: Morphine consumption at 48 hours. Started Mar 2010; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01143025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143025.